Halozyme Therapeutics Inc (HALO)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 194,942 | 205,185 | 210,582 | 203,283 | 192,361 | 182,183 | 174,679 | 158,552 | 139,304 | 118,771 | 90,041 | 79,116 | 81,413 | 86,098 | 73,077 | 55,799 | 43,367 | 33,782 | 50,547 | 46,684 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $194,942K ÷ $—K
= —
The payables turnover ratio for Halozyme Therapeutics Inc in the provided data is not available for any of the reported periods, which are from March 2020 to December 2024. The payables turnover ratio is a financial metric that indicates how efficiently a company is managing its accounts payable by measuring how many times a company pays off its average accounts payable balance in a given period.
Without the specific data on accounts payable and cost of goods sold, we cannot calculate or analyze the payables turnover ratio for Halozyme Therapeutics Inc. The lack of visibility into this ratio makes it challenging to assess the company's liquidity management, vendor relationships, and operational efficiency related to accounts payable turnover. Given this absence of information, it is not possible to draw any conclusions or provide insights into Halozyme Therapeutics Inc's payables turnover performance based on the available data.
Peer comparison
Dec 31, 2024